Tekla Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$29.4M Hold
228,747
1.15% 22
2023
Q1
$26.6M Buy
228,747
+10,732
+5% +$1.2M 1.01% 30
2022
Q4
$24.7M Sell
218,015
-27,697
-11% -$3.04M 0.93% 34
2022
Q3
$19.8M Buy
245,712
+115,828
+89% +$9.81M 0.81% 34
2022
Q2
$9.68M Sell
129,884
-16,800
-11% -$1.53M 0.38% 63
2022
Q1
$18.8M Sell
146,684
-21,040
-13% -$2.3M 0.66% 40
2021
Q4
$22.5M Sell
167,724
-4,196
-2% -$603K 0.72% 40
2021
Q3
$23.5M Sell
171,920
-159,100
-48% -$20.1M 0.76% 37
2021
Q2
$35.3M Buy
331,020
+32,448
+11% +$3.12M 1.15% 23
2021
Q1
$26.8M Hold
298,572
0.92% 26
2020
Q4
$27.6M Buy
298,572
+224,396
+303% +$20M 0.97% 29
2020
Q3
$7.64M Buy
74,176
+45,172
+156% +$4.72M 0.29% 82
2020
Q2
$2.94M Buy
+29,004
New +$2.59M 0.11% 141
2018
Q1
Sell
-215,800
Closed -$3.1M 190
2017
Q4
$3.1M Sell
215,800
-215,800
-50% -$2.81M 0.12% 108
2017
Q3
$5.28M Buy
431,600
+93,600
+28% +$1.65M 0.19% 86
2017
Q2
$6.18M Buy
338,000
+53,200
+19% +$983K 0.23% 78
2017
Q1
$6.03M Buy
+284,800
New +$5.56M 0.23% 78

Other funds holding DXCM

Tekla Capital Management's DXCM Position: Q2 2023 in Review

Tekla Capital Management held its DexCom (DXCM) position steady in Q2 2023 at 228,747 shares worth $29.4M. The position accounts for 1.15% of the portfolio, ranked #22.

Tekla Capital Management first reported a position in DXCM in Q1 2017 and has held it in 17 quarters since. The position peaked at $35.3M in Q2 2021. 955 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • Tekla Capital Management held 228,747 shares of DexCom worth $29.4M as of Q2 2023.
  • Tekla Capital Management left its DexCom share count unchanged in Q2 2023.
  • DexCom made up 1.15% of Tekla Capital Management's portfolio in Q2 2023, its #22 holding.
  • Tekla Capital Management first reported a position in DexCom in Q1 2017 and has held it in 17 quarters since.
  • Tekla Capital Management's DexCom position peaked at $35.3M in Q2 2021.
  • 955 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.